Navigation Links
Masimo to Report Second Quarter 2009 Financial Results on August 4, 2009
Date:7/22/2009

SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced Masimo Rainbow SET Pulse CO-Oximetry, a breakthrough noninvasive blood constituent monitoring platform that can measure many blood constituents that previously required invasive procedures. Rainbow SET continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO(R)), methemoglobin (SpMet(R)), and PVI(TM), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI), allowing early detection and treatment of potentially life-threatening conditions. Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications." Additional information about Masimo and its products may be found athttp://www.masimo.com.

    Masimo Corporation
    Investor Contact:                             Media Contact:
    Mark P. de Raad                               Dana Banks
    Executive Vice President and Chief            Manager, Public Relations
     Financial Officer                            Masimo Corporation
    Masimo Corporation                            (949) 297-7348
    (949) 297-7080                                dbanks@masimo.com
    mderaad@masimo.com

Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications, Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Radical-7, Rad-87, Rad-57, Rad-9, Rad-8, Rad-5, Pulse CO-Oximetry and Pulse CO-Oximeter are trademarks or registered trademarks of Masimo Corporation.


'/>"/>
SOURCE Masimo Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
2. Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume
3. Breaking Studies - Masimos Technologies the Focus of Multiple Clinical Studies at Last Weeks American Society of Anesthesiologists Annual Meeting
4. Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology
5. Masimo Corporation Adopts Stockholder Rights Plan
6. Masimo to Present at Piper Jaffray 19th Annual Healthcare Conference
7. Masimo Corporation Receives a Frost & Sullivan 2007 Industry Best Practices Award for Pulse Oximetry Leadership
8. Breaking Studies at AARC Congress Show Masimo SET and Masimo Rainbow SET to be Accurate, Effective and Uniquely Beneficial in Detecting and Tracking Disease States
9. Nationwide Respiratory Signs Preferred Pulse Oximetry Agreement with Masimo
10. Masimo to Present at 26th Annual JPMorgan Healthcare Conference
11. Masimo Celebrates 500,000th Pulse Oximeter Shipped
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... September as Brain Aneurysm Awareness Month , which was established by the ... , “Spreading awareness and education, and helping fund more research remains our top ...
(Date:9/2/2015)... ... September 02, 2015 , ... This Fall, as ... (BCAM), Bright Pink, a national non-profit focused on the prevention and early detection ... a campaign to educate women to be breast and ovarian self-aware and celebrate ...
(Date:9/1/2015)... CA (PRWEB) , ... September 01, 2015 , ... ... Business Times discusses the hundreds of thousands of plastic surgeries conducted each year ... and reality TV for the growing numbers. Beverly Hills-based plastic surgeon Payam Jarrah-Nejad, ...
(Date:9/1/2015)... ... September 01, 2015 , ... The Capillus82™ ... treatment of androgenic alopecia in adults, announces Miami-based medical device manufacturer, Capillus, LLC. ... also demonstrating its safety when used at home to combat hair loss. ...
(Date:9/1/2015)... ... September 01, 2015 , ... ProRehab Physical Therapy , ... partnership with Apex Physical Therapy (Apex) is official as of August ... compassionate, and empathetic care to local residents from their combined eight locations throughout ...
Breaking Medicine News(10 mins):Health News:September Celebrated as Brain Aneurysm Awareness Month 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 3Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3
... Safety Project Report Makes Recommendations for System in Critical Need ... Nov. 17 Weaknesses in food safety policy, organization and ... Saintpaul, according to a report released today by the Produce ... at Georgetown University . , ...
... MYL ) today announced that its subsidiary, Mylan ... Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) ... , Fluoxetine Capsules, indicated for ... version of Eli Lilly,s Sarafem(R) Pulvules(R) Capsules. This product had ...
... procedure in which her stem cells were combined with ... , , TUESDAY, Nov. 18 (HealthDay News) -- In a ... undergone the first transplantation of a breathing passage fashioned ... researchers report. , As of now, the woman, Claudia ...
... as Chairman, Tony Strange Appointed to CEO position and Will ... , MELVILLE, N.Y., Nov. 18 /PRNewswire-FirstCall/ ... ), a leading provider of comprehensive home health services, announced ... succession plan. Effective January 1, 2009, Tony Strange will ...
... and Policy Center (NLPC), a plaintiff in the successful 1993 ... Clinton,s health care task force, today criticized Barack Obama for ... , According to NLPC President Peter ... General. His track record is not one of independence or ...
... mechanisms, scientists show , , TUESDAY, Nov. 18 (HealthDay News) ... mechanisms, according to a Washington University study that challenges ... version of the body,s response to pain. , This ... itching and pain. , Zhou-Feng Chen, of Washington University,s ...
Cached Medicine News:Health News:Salmonella Saintpaul Outbreak Exposes Food Safety Weaknesses 2Health News:Salmonella Saintpaul Outbreak Exposes Food Safety Weaknesses 3Health News:Airway Transplant Aided by Stem Cells a Medical First 2Health News:Airway Transplant Aided by Stem Cells a Medical First 3Health News:Gentiva Health Services Confirms Management Succession 2Health News:Gentiva Health Services Confirms Management Succession 3Health News:Gentiva Health Services Confirms Management Succession 4Health News:NLPC Criticizes Obama's Choice of Eric Holder for Attorney General Because of Role in Health Care Task Force Cover-Up 2Health News:Itching Not a Less Intense Form of Pain 2
(Date:9/1/2015)... , Sept. 1, 2015 On August 31, ... Jr. , issued a 123-page order in the first ... Medical Conserve metal-on-metal hip replacement devices are defective.[1]  ... judgment as to Plaintiff Robyn Christiansen,s claims for defective ... Court flatly rejected Wright Medical,s claim that the Medical ...
(Date:9/1/2015)... and Delaware , ... Limited (ASX: IVX; "Company" or "Invion"), is pleased to announce ... following securities to an institutional investor in the ... gross proceeds of approximately A$1.001 million ("Placement") by the issue ... price of $0.014 per share. The Company ...
(Date:9/1/2015)... Nevro Corp. (NYSE: NVRO ), a ... solutions for the treatment of chronic pain, today announced ... the Patent Trial and Appeals Board (PTAB) in response ... filed by a unit of Boston Scientific Corporation, challenging ... 8,359,102 (the ,102 patent). The ,102 patent is one of Nevro,s 55 ...
Breaking Medicine Technology:Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial 2Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial 3Invion Announces Private Placement to US Institutional Investor 2Invion Announces Private Placement to US Institutional Investor 3Nevro Announces Submission of Preliminary Response to the Patent Trial and Appeals Board 2
... CRUZ, Calif., May 10, 2011 Bio Careers, the ... holding the world,s first Virtual Job Summit for life ... summit will enable employers to meet, converse with and ... of the top 50 U.S. training institutions—without leaving their ...
... today results from a post hoc analysis of the ... Rheumatology. The results suggest moderate to severe rheumatoid ... only approved PEGylated anti-TNF, together with methotrexate (MTX), achieved ... year after treatment began. "These results are ...
Cached Medicine Technology:Online Career Service to Hold World's First Virtual Job Summit for Postgraduate Life Scientists 2Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients 2Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients 3Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients 4Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients 5Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients 6Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients 7Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients 8Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients 9Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients 10
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: